LogicBio Therapeutics (LOGC) Misses Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Loss before taxes: -143.9K
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: +82.6%
Financial Fact:
Loss before taxes: -143.9K
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.08).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
- Nike beats quarterly estimates as tariff recovery boosts profit
- Allison Transmission to join S&P MidCap 400, Goodyear to move to S&P SmallCap 600
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
